319 related articles for article (PubMed ID: 9571355)
1. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.
Marfella R; Acampora R; Verrazzo G; Ziccardi P; De Rosa N; Giunta R; Giugliano D
Diabetes Care; 1996 Sep; 19(9):934-9. PubMed ID: 8875085
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
Weber K; Bohmeke T; van der Does R; Taylor SH
Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
Patel V; Rassam SM; Chen HC; Jones M; Kohner EM
Metabolism; 1998 Dec; 47(12 Suppl 1):28-33. PubMed ID: 9867068
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
Weber K; Bohmeke T; van der Does R; Taylor SH
Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
Cournot A; Lim C; Duchier J; Safar M
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
Ruilope LM
Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
[TBL] [Abstract][Full Text] [Related]
11. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
Nagakawa Y; Akedo Y; Kaku S; Orimo H
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
[TBL] [Abstract][Full Text] [Related]
13. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
15. Daytime-selective antihypertensive activity of celiprolol.
Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
[TBL] [Abstract][Full Text] [Related]
16. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
20. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]